These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7020182)

  • 21. Pharmacological immunosuppression in clinical organ grafting. Observations on four agents: cyclosporin A, Asta 5122 (cytimun), lambda carrageenan and promethazine hydrochloride.
    Calne RY
    Clin Exp Immunol; 1979 Jan; 35(1):1-9. PubMed ID: 371877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Renal allograft in dogs treated with antilymphotyce serum. Comparison between "in vitro" tests and immunodepressive effects of the serum].
    Dormont J; Eyquem A; Lavergne M; Lamy R; Bach J; de Montera H; Wallon C; Raynaud M
    Pathol Biol (Paris); 1969 Oct; 17(19):807-15. PubMed ID: 4907917
    [No Abstract]   [Full Text] [Related]  

  • 23. The interaction of cyclosporin A with other immunosuppressive agents in dog recipients of renal allografts.
    Homan WP; French ME; Fabre JW; Millard PR; Denton TG; Morris PJ
    Transplant Proc; 1980 Jun; 12(2):287-90. PubMed ID: 6994297
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of rapamycin on renal allograft survival in canine recipients treated with antilymphocyte serum, donor bone marrow, and cyclosporine.
    Hartner WC; Van der Werf WJ; Lodge JP; Gilchrist B; De Fazio SR; Markees TG; Yatko C; Monaco AP; Gozzo JJ
    Transplantation; 1995 Dec; 60(11):1347-50. PubMed ID: 8525533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporin A in organ transplantation.
    Calne RY; Rolles K; White DJ; Thiru S; Evans DB; McMaster P; Dunn DC; Craddock GN; Henderson RG; Aziz S; Lewis P
    Adv Nephrol Necker Hosp; 1981; 10():335-47. PubMed ID: 6791475
    [No Abstract]   [Full Text] [Related]  

  • 26. Use of cyclosporin-A despite renal dysfunction.
    Keown PA; Stiller CR; Ulan RA
    N Engl J Med; 1981 Jul; 305(4):227-8. PubMed ID: 7017412
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
    Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
    Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo immunosuppressive effect of purine nucleoside phosphorylase inhibitor-8-amino-9-benzyl-guanine in canine renal allograft rejection.
    Lin CY; Yen CY
    Transplant Proc; 1994 Dec; 26(6):3126-7. PubMed ID: 7998091
    [No Abstract]   [Full Text] [Related]  

  • 29. Transplant surgery.
    Majeski JA
    Am Fam Physician; 1981 Sep; 24(3):157-60. PubMed ID: 7023213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Persistent nonspecific immunosuppression after a course of cyclosporin A.
    Dunn DC; White DJ; Herbertson BM
    Transplantation; 1980 Apr; 29(4):349-51. PubMed ID: 6445105
    [No Abstract]   [Full Text] [Related]  

  • 31. The effect of cyclosporin A on the primary and secondary immune responses in the rabbit.
    Lindsey NJ; Harris KR; Norman HB; Smith JL; Lee HA; Slapek M
    Transplant Proc; 1980 Jun; 12(2):252-5. PubMed ID: 7394880
    [No Abstract]   [Full Text] [Related]  

  • 32. Two random transfusions before primary renal transplantation--four years' experience from a single center.
    Frisk B; Brynger H; Sandberg L
    Transplant Proc; 1982 Jun; 14(2):386-8. PubMed ID: 7051484
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of antilymphocyte serum on renal allograft survival in dogs with special reference to the cytotoxic titer and immunosuppressive activity.
    Matsukura M; Sekiguchi M; Endo S; Kurosawa T; Koishi T
    Jpn J Exp Med; 1971 Aug; 41(4):369-73. PubMed ID: 4936584
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of HLA typing and transfusions on cyclosporine-treated renal-allograft recipients.
    Cats S; Terasaki P; Perdue S; Mickey MR
    N Engl J Med; 1984 Sep; 311(10):675-6. PubMed ID: 6382003
    [No Abstract]   [Full Text] [Related]  

  • 35. In vivo immunosuppressive effect and the decreasing expression of MHC class II antigens by purine nucleoside phosphorylase inhibitor 8-amino-9-benzylguanine in recipient tissues of canine renal allograft rejection.
    Yen CY; Lin CY
    J Surg Res; 1996 May; 62(2):260-6. PubMed ID: 8632649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoma in renal allograft patients treated with cyclosporin-A as one of the immunosuppressive agents.
    Thiru S; Calne RY; Nagington J
    Transplant Proc; 1981 Mar; 13(1 Pt 1):359-64. PubMed ID: 7022852
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of cyclosporin A on experimental graft-versus-host disease in rodents.
    van Bekkum DW; Knaan S; Zurcher C
    Transplant Proc; 1980 Jun; 12(2):278-82. PubMed ID: 6994295
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants.
    Calne RY; White DJ; Pentlow BD; Rolles K; Syrakos T; Ohtawa T; Smith DP; McMaster P; Evans DB; Herbertson BM; Thiru S
    Transplant Proc; 1979 Mar; 11(1):860-4. PubMed ID: 377719
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclosporin.
    Calne RY
    Nephron; 1980; 26(2):57-63. PubMed ID: 6997765
    [No Abstract]   [Full Text] [Related]  

  • 40. An evaluation of leflunomide in the canine renal transplantation model.
    McChesney LP; Xiao F; Sankary HN; Foster PF; Sharma S; Haklin M; Williams JW
    Transplantation; 1994 Jun; 57(12):1717-22. PubMed ID: 8016874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.